Measurement of urinary N-telopeptides and serum C-telopeptides from type I collagen using a lateral flow-based immunoassay

Sensors (Switzerland)

Volumn 13, Issue 1, 2013, Pages 165-174

  Lee, Kyoung Min ^a   Lee, Min Ho ^b   Chung, Chin Youb ^a   Seong, Woo Kyeong ^b   Lee, Sang Dae ^c   Park, Moon Seok ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Korea Electronic Technology Institute (KETI)   (South Korea)

^c IM Electronics   (South Korea)

Author keywords

Bone turnover marker; Lateral flow immunoassay; Osteoporosis; Serum C telopeptide; Urine N telopeptide

Indexed keywords

BONE TURNOVER; LATERAL FLOW IMMUNOASSAY; OSTEOPOROSIS; SERUM C-TELOPEPTIDE; URINE N-TELOPEPTIDE;

BIOASSAY; DISEASES; IMMUNOLOGY;

BODY FLUIDS;

ANTISERUM; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

AGED; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW KINETICS; HUMAN; IMMUNOASSAY; MALE; METABOLISM; METHODOLOGY; MOUSE; URINE;

AGED; ANIMALS; COLLAGEN TYPE I; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNE SERA; IMMUNOASSAY; MALE; MICE; MICE, INBRED BALB C; PEPTIDES; RHEOLOGY;

EID: 84872770326     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s130100165     Document Type: Article

References (24)

1. Grey, A.; Bolland, M.J. The effect of treatments for osteoporosis on mortality. Osteoporos. Int. 2012, in press.
2. Cummings, S.R.; Black, D. Bone mass measurements and risk of fracture in Caucasian women: A review of findings from prospective studies. Am. J. Med. 1995, 98, 24S-28S.
3. Johnell, O.; Gullberg, B.; Kanis, J.A.; Allander, E.; Elffors, L.; Dequeker, J.; Dilsen, G.; Gennari, C.; Lopes, V.A.; Lyritis, G.; et al. Risk factors for hip fracture in European women: The MEDOS Study. Mediterranean Osteoporosis Study. J. Bone. Miner. Res. 1995, 10, 1802-1815.
4. Cummings, S.R.; Black, D.M.; Nevitt, M.C.; Browner, W.; Cauley, J.; Ensrud, K.; Genant, H.K.; Palermo, L.; Scott, J.; Vogt, T.M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993, 341, 72-75.
5. El Maghraoui, A.; Mouinga Abayi, D.A.; Ghozlani, I.; Mounach, A.; Nouijai, A.; Ghazi, M.; Mora, S.; Prinster, C.; Proverbio, M.C.; Bellini, A.; et al. Urinary markers of Bone turnover in healthy children and adolescents: Age-related changes and effect of puberty. Calcif. Tissue. Int. 1998, 63, 369-374.
6. Reginster, J.Y.; Collette, J.; Neuprez, A.; Zegels, B.; Deroisy, R.; Bruyere, O. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 2008, 42, 832-836.
7. Vasikaran, S.D.; Glendenning, P.; Morris, H.A. The role of biochemical markers of bone turnover in osteoporosis management in clinical practice. Clin. Biochem. Rev. 2006, 27, 119-121.
8. Garnero, P. Biomarkers for osteoporosis management. Mol. Diag. Ther. 2008, 12, 157-170.
9. Blumsohn, A.; Hannon, R.A.; Wrate, R.; Barton, J.; Al-Dehaimi, A.W.; Colwell, A.; Eastell, R. Biochemical markers of bone turnover in girls during puberty. Clin. Endocrinol. 1994, 40, 663-670.
10. Iba, K.; Takada, J.; Hatakeyama, N.; Ozasa, Y.; Wada, T.; Yamashita, T. Changes in urinary NTX levels in patients with primary osteoporosis undergoing long-term bisphosphonate treatment. J. Orthop. Sci. 2008, 13, 438-441.
11. Rosen, H.N.; Moses, A.C.; Garber, J.; Iloputaife, I.D.; Ross, D.S.; Lee, S.L.; Greenspan, S.L. Serum CTX: A new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif. Tissue. Int. 2000, 66, 100-103.
12. Gubala, V.; Harris, L.F.; Ricco, A.J.; Tan, M.X.; Williams, D.E. Point of care diagnostics: Status and future. Anal. Chem. 2012, 84, 487-515.
13. Qu, Q.; Zhu, Z.; Wang, Y.; Zhong, Z.; Zhao, J.; Qiao, F.; Du, X.; Wang, Z.; Yang, R.; Huang, L.; Yu, Y.; Zhou, L.; Chen, Z. Rapid and quantitative detection of Brucella by up-converting phosphor technology-based lateral-flow assay. J. Microbiol. Methods 2009, 79, 121-123.
14. Frens, G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 1973, 241, 20-22.
15. Kimling, J.; Maier, M.; Okenve, B.; Kotaidis, V.; Ballot, H.; Plech, A. Turkevich method for gold nanoparticle synthesis revisited. J. Phys. Chem. B 2006, 110, 15700-15707.
16. Hanson, D.A.; Weis, M.A.; Bollen, A.M.; Maslan, S.L.; Singer, F.R.; Eyre, D.R. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urine. J. Bone Miner. Res. 1992, 7, 1251-1258.
17. Lee, M.; Chung, Y.C.; Lee, K.M.; Seong, W.K.; Kim, K.S.; Lee, S.D.; Park, M.S. Measurement of urinary N-telopeptides from type I collagen using a colloidal gold-based immunoassay. J. Biotechnol. 2011, 153, 176-180.
18. Findlay, J.W.; Dillard, R.F. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 2007, 9, E260-E267.
19. McGraw, K.O.; Wong, S.P. Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1996, 1, 30-46.
20. Bonett, D.G. Sample size requirements for estimating intraclass correlations with desired precision. Stat. Med. 2002, 21, 1331-1335.
21. Marx, R.E.; Cillo, J.E., Jr.; Ulloa, J.J. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J. Oral. Maxillofac. Surg. 2007, 65, 2397-2410.
22. Rosen, H.N.; Moses, A.C.; Garber, J.; Ross, D.S.; Lee, S.L.; Greenspan, S.L. Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates. Calcif. Tissue. Int. 1998, 63, 363-368.
23. Baxter, I.; Rogers, A.; Eastell, R.; Peel, N. Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice. Osteoporos. Int. 2012, in press.
24. Bjarnason, N.H.; Henriksen, E.E.; Alexandersen, P.; Christgau, S.; Henriksen, D.B.; Christiansen, C. Mechanism of circadian variation in bone resorption. Bone 2002, 30, 307-313.